Life Sciences
Why Are CRISPR Therapeutics Charts Saying 'Buy'?
Here's where traders could go long.
Intuitive Surgical's Charts Are Flashing Positive Signs Ahead of Earnings
The maker of robotic products for minimally invasive surgery looks like a long play based on its technical signals.
Regeneron Set to Reach New Heights: $1,000 in Sight?
Here's how traders can play it.
Johnson & Johnson's Rally Does Not Move the Needle
It will take more than the company's potential talc litigation settlement to reverse the stock's downward path the past 12 months.
Boston Scientific's Wicked Rally Can Take the Stock 20% Higher
BSX has rallied the past nine months.
Novavax's Charts Are in Critical Condition
Trying to catch this drug developer's stock appears risky.
It's Time to Reevaluate Moderna's Charts
Here's what I think we'll see up ahead.
Are Danaher Shares Poised for a Rally?
Keep this stock on your watch list.
Illumina's Disappointing 2023 Guidance Sends Shares Lower
Here's what to avoid for now.
NovoCure Gaps Sharply Higher for a Breakout: How to Play It
Let's check out the charts and indicators of both NovoCure and Zai Lab.